Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA037161-03S1
Application #
3174919
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1984-09-01
Project End
1987-09-29
Budget Start
1986-09-01
Budget End
1987-09-29
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Hospitals
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Ridley, R C; Xiao, H; Hata, H et al. (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81:767-74
Hata, H; Xiao, H; Petrucci, M T et al. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 81:3357-64
Kreitman, R J; Siegall, C B; FitzGerald, D J et al. (1992) Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma. Blood 79:1775-80
Thomas, X; Xiao, H Q; Chang, R et al. (1992) Circulating B lymphocytes in multiple myeloma patients contain an autocrine IL-6 driven pre-myeloma cell population. Curr Top Microbiol Immunol 182:201-7
Barlogie, B; Gale, R P (1992) Multiple myeloma and chronic lymphocytic leukemia: parallels and contrasts. Am J Med 93:443-50
Jagannath, S; Vesole, D H; Glenn, L et al. (1992) Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 80:1666-72
Alexanian, R; Barlogie, B; Gutterman, J (1991) Alpha-interferon combination therapy of resistant myeloma. Am J Clin Oncol 14:188-92
Barlogie, B; Gahrton, G (1991) Bone marrow transplantation in multiple myeloma. Bone Marrow Transplant 7:71-9
Dimopoulos, M A; Barlogie, B; Smith, T L et al. (1991) High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma. Ann Intern Med 115:931-5
Barlogie, B; Jagannath, S; Dixon, D O et al. (1990) High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma. Blood 76:677-80

Showing the most recent 10 out of 39 publications